Skip to content

Clinical trials

Phase 1 Stomach Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 1 Country / region: Germany Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20072
20081
20121
20141
20161
20171
20203
20221
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting4
Active, not recruiting2
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Technical University of Munich2
Amgen1
AstraZeneca1
BioNTech Cell & Gene Therapies GmbH1
Boehringer Ingelheim1
Exelixis1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
Krankenhaus Nordwest1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms17
Colorectal Neoplasms8
Breast Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Endometrial Neoplasms4
Esophageal Neoplasms4
Ovarian Neoplasms4
Carcinoma, Hepatocellular3
Pancreatic Neoplasms3
Cholangiocarcinoma2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.